A phase Ib randomized, placebo-controlled study evaluating the safety, pharmacokinetics, pharmacodynamics, and efficacy of crovalimab for the management of acute uncomplicated vaso-occlusive episodes in patients with sickle cell disease

A clinical trial to evaluate the safety and effectiveness of crovalimab for the treatment of pain crises, also called vaso-occlusive episodes (VOE), in people with sickle cell disease (SCD)